Bibliography
- Renslo AR, McKerrow JH. Drug discovery and development for neglected parasitic diseases. Nat Chem Biol 2006;2(12):701-10
- Herrling PL. Financing R&D for neglected diseases. Nat Rev Drug Discov 2009;8(2):727-40
- Guido RVC, Oliva G. Structure-based drug discovery for tropical diseases. Curr Top Med Chem 2009;9(9):824-43
- Guido RVC, Oliva G, Andricopulo AD. Virtual screening and its integration with modern drug design technologies. Curr Med Chem 2008;15(1):37-46
- Montero-Torres A, Garcia-Sanchez RN, Marrero-Ponce Y, Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental assessment of a promising method for the discovery of new antimalarial compounds. Eur J Med Chem 2006;41(4):483-93
- Vega MC, Montero-Torres A, Marrero-Ponce Y, New ligand-based approach for the discovery of antitrypanosomal compounds. Bioorg Med Chem Lett 2006;16(7):1898-904
- Trossini GHG, Guido RVC, Oliva G, Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies. J Mol Graph Model 2009;28(1):3-11
- Postigo MP, Guido RVC, Oliva G, Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening. J Chem Inf Model 2010;50(9):1693-705
- Ferreira RS, Simeonov A, Jadhav A, Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem 2010;53(13):4891-905
- Andricopulo AD, Salum LB, Abraham DJ. Structure-based drug design strategies in medicinal chemistry. Curr Top Med Chem 2009;9(9):771-90
- Freitas RF, Prokopczyk IM, Zottis A, Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors. Bioorg Med Chem 2009;17(6):2476-82
- Perez-Pineiro R, Burgos A, Jones DC, Development of a novel virtual screening cascade protocol to identify potential trypanothione reductase inhibitors. J Med Chem 2009;52(6):1670-80
- Tan L, Geppert H, Sisay MT, Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets. ChemMedChem 2008;3(10):1566-71
- Weber KC, Salum LB, Honorio KM, Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands. Eur J Med Chem 2010;45(4):1508-14
- Hert J, Willett P, Wilton DJ, New methods for ligand-based virtual screening: use of data fusion and machine learning to enhance the effectiveness of similarity searching. J Chem Inf Model 2006;46(2):462-70
- Geppert H, Vogt M, Bajorath J. Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation. J Chem Inf Model 2010;50(2):205-16
- Eckert H, Bojorath J. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov Today 2007;12(5-6):225-33
- Guido RV, Trossini GH, Castilho MS, Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi. J Enzyme Inhib Med Chem 2008;23(6):964-73
- Guido RVC, Oliva G, Montanari CA, Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies. J Chem Inf Model 2008;48(4):918-29
- Guido RVC, Castilho MS, Mota SGR, Classical and hologram QSAR studies on a series of inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. QSAR Comb Sci 2008;27(6):768-81
- Perez-Villanueva J, Santos R, Hernandez-Campos A, Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg Med Chem 2010;18(21):7380-91
- Gonzalez-Diaz H, Olazabal E, Santana L, QSAR study of anticoccidial activity for diverse chemical compounds: Prediction and experimental assay of trans-2-(2-nitrovinyl)furan. Bioorg Med Chem 2007;15(2):962-8
- Marrero-Ponce Y, Meneses-Marcel A, Castillo-Garit JA, Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs. Bioorg Med Chem 2006;14(19):6502-24
- Guido RVC, Castilho MS, Oliva G, Structure-based pharmacophore strategies in drug design, 2008. In: Taft CA, Silva CHTP, editors, Current methods in medicinal chemistry and biological physics. Volume 2. Research Signpost, Kerala, India; 2008. p. p1-19
- Castilho MS, Postigo MP, de Paula CBV, Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors. Bioorg Med Chem 2006;14(2):516-27
- Castilho MS, Postigo MP, Pereira HM, Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: kinetic and structural studies. Bioorg Med Chem 2010;18(4):1421-7
- Kortagere S, Welsh WJ, Morrisey JM, Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum. J Chem Inf Model 2010;50(5):840-9
- Mpamhanga CP, Spinks D, Tulloch LB, One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening. J Med Chem 2009;52(14):4454-65
- Kolb P, Ferreira RS, Irwin JJ, Docking and chemoinformatic screens for new ligands and targets. Curr Opin Biotechnol 2009;20(4):429-36
- Colizzi F, Perozzo R, Scapozza L, Single-molecule pulling simulations can discern active from inactive enzyme inhibitors. J Am Chem Soc 2010;132(21):7361-71